Tumor Immune Microenvironment and Nivolumab Efficacy in...

  • Main
  • 2017 / 04
  • Tumor Immune Microenvironment and Nivolumab Efficacy in...

Tumor Immune Microenvironment and Nivolumab Efficacy in EGFR Mutation–Positive Non–Small Cell Lung Cancer Based on T790M Status after Disease Progression During EGFR-TKI Treatment

Haratani, K., Hayashi, H., Tanaka, T., Kaneda, H., Togashi, Y., Sakai, K., Hayashi, K., Tomida, S., Chiba, Y., Yonesaka, K., Nonagase, Y., Takahama, T., Tanizaki, J., Tanaka, K., Yoshida, T., Tanimura
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Language:
english
Journal:
Annals of Oncology
DOI:
10.1093/annonc/mdx183
Date:
April, 2017
File:
PDF, 1.07 MB
english, 2017
Conversion to is in progress
Conversion to is failed